Clinical Trials Study Open Access
Copyright ©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Psychiatry. Apr 19, 2025; 15(4): 103362
Published online Apr 19, 2025. doi: 10.5498/wjp.v15.i4.103362
Mindfulness improves negative psychotic symptoms through reducing emotional and social withdrawal
Carmen Borrás-Sansaloni, Marina Ricco-Pérez, Capilla Navarro-Guzmán, Emilio Lopez-Navarro, Department of Psychology, University of Balearic Islands, Palma 07122, Balearic Islands, Spain
Carmen Borrás-Sansaloni, Marina Ricco-Pérez, Capilla Navarro-Guzmán, José Manuel García-Montes, Emilio Lopez-Navarro, Beatles Research Group, University of Balearic Islands, Palma 07122, Balearic Islands, Spain
Antoni Mayol, UCR Serralta, Balearic Public Health Service, Palma 07013, Balearic Islands, Spain
Antoni Mayol, Human Evolution and Cognition Research Group, University of the Balearic Islands, Palma 07122, Balearic Islands, Spain
José Manuel García-Montes, Department of Psychology, University of Almería, Almeria 04120, Andalusia, Spain
ORCID number: Carmen Borrás-Sansaloni (0009-0005-2318-5786); Marina Ricco-Pérez (0009-0005-6889-3831); Antoni Mayol (0000-0002-3783-6675); Capilla Navarro-Guzmán (0000-0002-5805-0954); José Manuel García-Montes (0000-0001-8410-9115); Emilio Lopez-Navarro (0000-0002-0240-9278).
Author contributions: Borrás-Sansaloni C, Mayol A, Navarro-Guzmán C, and Lopez-Navarro E contributed to conceptualization; Navarro-Guzmán C and Lopez-Navarro E contributed to methodology; Ricco-Pérez M and Navarro-Guzmán C performed the formal analysis; Borrás-Sansaloni C, Ricco-Pérez M, and Mayol A contributed to the investigation; Borrás-Sansaloni C and Mayol A contributed to resources; Borrás-Sansaloni C, Ricco-Pérez M, and Lopez-Navarro E wrote the original draft; Borrás-Sansaloni C, Ricco-Pérez M, Mayol A, Navarro-Guzmán C, and Lopez-Navarro E reviewed and edited the draft; Lopez-Navarro E supervised the study and contributed to project administration; Mayol A, Navarro-Guzmán C, and Lopez-Navarro E acquired funding; All authors read and agreed to the published version of the manuscript.
Supported by the R+D Project funded by the Spanish Ministry of Science and Innovation MCIN/AEI/10.13039/501100011033 and by FEDER, EU, No. PID2021-122987OA-I00.
Institutional review board statement: The study was reviewed and approved by the Research Ethics Committee of the University of Balearic Islands, No. 6163/1806/2015.
Clinical trial registration statement: This study is registered at ISRCTN registry (No. ISRCTN52873519).
Informed consent statement: All study participants, or their legal guardian, provided informed written consent prior to study enrollment.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
CONSORT 2010 statement: The authors have read the CONSORT 2010 Statement, and the manuscript was prepared and revised according to the CONSORT 2010 Statement.
Data sharing statement: The datasets generated are available from the corresponding author on reasonable request.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Emilio Lopez-Navarro, PhD, Assistant Professor, Department of Psychology, University of Balearic Islands, Valldemossa Road, Palma 07122, Balearic Islands, Spain. emilio.lopez@uib.es
Received: November 18, 2024
Revised: January 6, 2025
Accepted: February 17, 2025
Published online: April 19, 2025
Processing time: 127 Days and 15 Hours

Abstract
BACKGROUND

Psychotic disorders are characterized by both positive symptoms (hallucinations, delusions) and negative symptoms (emotional blunting, anhedonia) that impair daily functioning. While antipsychotic drugs and psychological interventions are effective when addressing positive symptoms, treatment of negative symptoms remains an ongoing challenge. Mindfulness-based interventions (MBIs) have been shown to reduce negative psychotic symptoms. However, as negative psychotic symptoms are assessed as a sole entity rather than a sum of manifestations, the effect of MBIs remains unclear.

AIM

To examine the effects of MBI in addition to integrated rehabilitation treatment (IRT) for people experiencing psychosis on each of the negative psychotic symptoms.

METHODS

A randomized controlled clinical trial with preintervention and postintervention measures was designed. The main outcome variable was negative psychotic symptoms assessed through the seven subscales of the Spanish version of the positive and negative syndrome scale. Data were analyzed using a repeated measures analysis of variance and reliable change index calculation.

RESULTS

There were no statistical differences between groups at the preintervention assessment. Statistically significant differences were found after MBI for the time in emotional withdrawal (F = 37.75, P < 0.001, η2 = 0.437) and social withdrawal (F = 37.75, P < 0.001, η2 = 0.437).

CONCLUSION

MBI added to IRT reduced the lack of interest and involvement with affective commitment to daily life activities, and interest and engagement in social activities increased. These negative psychotic symptoms were not improved by IRT alone.

Key Words: Mindfulness; Psychosis; Clinical trial; Emotional withdrawal; Social functioning; Schizophrenia

Core Tip: Mindfulness-based interventions when combined with integrated rehabilitation treatment significantly reduced emotional and social withdrawal in people with psychosis. These specific negative symptoms were not improved by integrated rehabilitation alone. This effect may be attributed to the role of mindfulness in fostering acceptance of psychotic experiences, enhancing emotional engagement, and promoting social interaction. The study highlights the potential for mindfulness as a valuable adjunct to rehabilitation treatment.



INTRODUCTION

Psychosis is a mental disorder characterized by both positive and negative symptomatology and impaired social functioning[1-3]. Positive symptoms entail an amplification or distortion of normal functions, including hallucinations, delusions, and disordered thinking. In contrast, negative symptoms refer to the reduction of a normal function affecting core domains for a person’s daily functioning, i.e. blunted affect, diminished emotional expression, anhedonia, or lack of interest in social affairs. Psychotic disorders also imply a high economic cost ranging between 0.02% and 1.65% of the gross domestic product in developed countries[4], making them among the most financially burdensome diagnoses. Negative symptoms are at the core of the impairment in daily life functioning, accounting for more than the 70% (indirect cost) of the total costs[5].

Positive symptoms have shown a favorable response to both antipsychotics and psychological interventions[1,6]. However, addressing negative symptoms remains an ongoing challenge[7]. The development of pharmacological treatments for negative symptoms has not progressed as swiftly as it has for positive symptoms[8], leading to various proposals for the future of pharmacological treatment research in psychoses[9]. On the other hand, psychosocial interventions have demonstrated a small to moderate effect and are well accepted by patients and their families. Among psychological therapies, cognitive behavioral therapy for psychosis has the most substantial evidence in its favor. However, according to a recent systematic review of meta-analyses[10], the effectiveness of cognitive behavioral therapy reducing negative symptoms was not superior to an active control condition in clinical trials. In contrast with cognitive behavioral therapy for psychosis, mindfulness-based interventions (MBIs) have been shown as a promising treatment option due to its effectiveness in reducing negative symptoms compared to active control conditions[11]. MBI also has a high patient acceptance rate[12].

MBIs applied to psychoses aim to foster acceptance rather than confronting the individual with psychotic experiences[13]. To do so MBIs help people experiencing psychotic experiences to remain in contact and react with acceptance rather than struggling or avoidance[14]. Therefore, the theoretical background is different from that of cognitive behavioral therapy for psychosis[15]. MBIs have shown positive findings enhancing the quality of life in people experiencing psychosis[16,17]. The improvement on quality of life is accounted for as a modification of the relationship with the content of positive symptoms[18] as well as for the mediation role of dispositional mindfulness between psychotic experiences and psychological well-being[19].

MBI also improves social cognition in psychotic disorders as shown by López-Navarro et al[20] and Mediavilla et al[21]. Although there are no crucial findings about the processes accountable for this effect, it has been suggested that mindfulness applied to psychosis enhances inhibitory control, which is a key cognitive process for social cognition[22]. A growing body of evidence suggests that MBIs are effective at reducing negative symptoms with effect sizes ranging from small to moderate[10,23-25]. However, in contrast with psychological quality of life or social cognition, the mechanism by which MBIs reduce negative symptoms remains unknown.

A common challenge in studying the effectiveness of interventions targeting negative symptoms is that they are grouped into one general category[9]. Therefore, to the best of our knowledge, no study has conducted a detailed assessment of the effects of MBIs on the different manifestations of negative symptoms. We reanalyzed data from a previous randomized controlled trial addressing the effects of mindfulness added to rehabilitation treatment of people diagnosed with severe mental illness to determine how mindfulness improves negative symptoms. The new analysis strategy sought to examine the effects of both treatments on negative symptoms.

MATERIALS AND METHODS
Study design

A randomized controlled clinical trial with preintervention and postintervention measures was designed for implementation in a naturalistic rehabilitation setting. There were two treatment arms: Integrated rehabilitation treatment (IRT); and IRT enhanced with MBI (IRT + MBI). The main outcome variable was negative psychotic symptoms. The trial was registered in the ISRCTN Registry (No. ISRCTN52873519). The study complied with the Declaration of Helsinki and was approved by the Research Ethics Committee of the University of Balearic Islands (No. 6163/1806/2015).

Participants

Participants were recruited from a community rehabilitation center in Spain. The study sample comprised a total of 52 randomized outpatients. The mean age of the sample was 39.71 ± 8.98 years with a mean duration of disorder of 14.13 ± 7.66 years. Most of the participants were male (78.8%), and the mean number of years of education was 12.04 ± 2.08. Participants were not employed and did not receive any financial compensation for their involvement in the research.

Eligibility criteria for participation included: (1) Age between 18 and 65 years; (2) Diagnosis of a psychotic disorder according to clinical record; (3) Stability in antipsychotic medication and absence of hospitalization in the preceding month; (4) Signed the informed consent; and (5) Proficiency in understanding and reading Spanish. Criteria for exclusion encompassed: (1) Significant cognitive deficits determined via clinical record or any medical condition that could potentially interfere with the outcomes of the intervention (e.g., dementia or stroke); (2) Inability to participate in mindfulness or rehabilitation treatment sessions; and (3) Refusal to engage in the study or to provide informed consent.

Instruments and procedure

The clinical and demographic characteristics of the sample were gathered using a structured record, which included information on age, sex, years since diagnosis, number of years of education, and clinical diagnosis. To assess the primary outcome variable, we used the Spanish version of the positive and negative syndrome scale (PANSS)[26]. The PANSS assesses symptom severity in people with psychosis. We focused on the seven indexes that conform the negative subscale: Blunted affect; emotional withdrawal; poor rapport; social withdrawal; difficulty in abstract thinking; lack of spontaneity and flow of conversation; and stereotyped thinking. Table 1 provides detailed information of the content included by each subscale.

Table 1 Definition of the positive and negative syndrome scale negative subscales.
PANSS negative subscale
Definition
Blunted affectDiminished emotional responsiveness as characterized by a reduction in facial expression, modulation of feelings, and communicative gestures
Emotional withdrawalLack of interest in, involvement with, and affective commitment to life’s events
Poor rapportLack of interpersonal empathy, openness in conversation, and sense of closeness, interest, or involvement with the others
Social withdrawalDiminished interest and initiative in social interactions due to passivity, apathy, anergy, or avolition. This leads to reduced interpersonal involvement and neglect of activities of daily living
Difficulty in abstract thinkingImpairment in the use of the abstract-symbolic mode of thinking, as evidenced by difficulty in classification, forming generalizations, and proceeding beyond concrete or egocentric thinking
Lack of spontaneity and flow of conversationReduction in the normal flow of communication associated with apathy, avolition, defensiveness, or cognitive deficit
Stereotyped thinkingDecreased fluidity, spontaneity, and flexibility of thinking, as evidenced in rigid, repetitious, or barren thought content

To enhance external validity both the assessment and intervention protocols were naturally encompassed into the participants’ daily routines and the framework of a rehabilitation center within the public health system. A clinical psychologist from the center contacted potential participants to schedule an interview during which they received detailed information about the study and underwent an eligibility assessment. This session was designed to provide comprehensive information about the study and to evaluate their eligibility. Those considered eligible were then invited to participate.

Upon obtaining signed informed consent, each participant was assigned a randomization ID, which was documented in the clinical record form. A confidential master randomization list was maintained, accessible only to the principal investigator and the clinical team responsible for conducting the mindfulness sessions. The assessment of participants was carried out by a clinical psychologist who was not informed of the participants’ group assignments. Interviews were videotaped and scored at the end of the treatment arms by two clinical psychologists who were blinded to treatment allocation.

Following the assessment the last author assigned participants randomly by software to either the IRT group or the IRT + MBI group, ensuring that MBI groups maintained an optimal size of 8 to 12 participants. Randomization was conducted once a sufficient number of participants were available to start a mindfulness group (Figure 1). Data collection took place at the same community rehabilitation center, and missing data were handled using an intention-to-treat analysis.

Figure 1
Figure 1 CONSORT flowchart. IRT: Integrated rehabilitation treatment; MBI: Mindfulness-based intervention.
Intervention

There were two treatment arms: IRT and IRT + MBI. Both treatment arms were administered by clinical staff who were trained in rehabilitation strategies and treatment of people experiencing psychosis. Clinical staff also received additional training in mindfulness applications for psychosis for those involved in the IRT + MBI arm. The IRT arm spanned 26 weeks, with a focus on managing the intensity and frequency of psychotic symptoms, preventing relapses and hospitalizations, and enhancing social functioning. The program included 26 weekly group sessions, each lasting 1 h, that incorporated cognitive behavioral therapy techniques for symptom management, strategies for relapse prevention, and conflict resolution skills. Recognizing the mediating role of daily life stressors in the nexus between psychotic experiences and psychological well-being[27], IRT had a strong social skills training component.

The initial six sessions were dedicated to educating participants on the A-B-C model and elucidating the interconnections between feelings, thoughts, and the environment. The model consists of three components: A (activating event); B (beliefs); and C (consequences). The activating event refers to specific psychotic experiences, such as hearing voices or perceiving others as threatening. These symptoms often lead to beliefs that involve misinterpretations, such as “the voices are controlling me” or “people are planning to harm me”. These beliefs in turn result in consequences like distress, paranoia, or avoidance behaviors.

In sessions seven to nine, therapists worked collaboratively with individuals to identify real-life situations brought up by participants to exemplify the A-B-C model. Also, during these sessions, participants examined the evidence for and against their beliefs, explored alternative explanations, and reduced the automatic emotional or behavioral responses tied to their symptoms. The tenth to the sixteenth sessions focused on teaching social skills and assertiveness techniques, which were then applied in role-playing exercises during sessions seventeen to twenty. The concluding sessions, twenty-one to twenty-six, were aimed at applying problem-solving strategies to socially challenging situations identified by participants as distressing. In addition to the group sessions and to further prevent relapses and hospitalization, each participant underwent a weekly interview to review and adjust pharmacotherapy as needed. Unlike the MBI-enhanced arm, the standard IRT protocol did not include mindfulness training or family intervention components.

The IRT + MBI group was conducted alongside the 26-week rehabilitation program, integrating mindfulness practices following the framework established by López-Navarro et al[20]. To ensure adherence to the protocol, the last author monitored 80% of the sessions, verifying treatment fidelity. The mindfulness sessions aimed to change participants’ reactions to their own psychotic experiences, fostering an attitude of acceptance rather than resistance towards the experiences that could arise. The mindfulness training encouraged participants to recognize voices or thoughts for what they truly are rather than the content they convey.

Each mindfulness therapy session lasted for 60 min and was hosted in a facility provided at no cost by the local government. Sessions commenced with a period of habituation to the environment accompanied by calming music to recognize the role of physical sensations in grounding individuals in the present moment, especially within the context of psychosis. This was followed by a 10-min body awareness exercise, led by a psychologist trained in mindfulness. Subsequently, a 15-min guided meditation session was conducted by a psychiatrist and a clinical psychologist, both specializing in mindfulness and with experience in treating psychotic patients. Instruction during these sessions emphasized the cultivation of awareness and acceptance of various sensations, including bodily feelings, breath sensations, and any arising thoughts, images, or voices.

The goal was to encourage participants to observe and release engagement with the content of these experiences, including thoughts, voices, or other symptoms of psychosis and to refrain from judgement or criticism. The mindfulness sessions concluded with a 15-min period of reflective group discussion designed to deepen patients’ understanding and insights from the mindfulness exercises. To support continuous practice, participants were encouraged to engage in mindfulness exercises at home and were provided with an audio recording featuring the guided instructions from the sessions for home use.

Statistical analysis

Descriptive statistics were computed for the clinical and demographic characteristics of the overall sample and separately for each treatment group. Prior to analyzing the outcome variables, assumptions of normality and homoscedasticity were tested with the Shapiro-Wilk test and Levene’s test. Groups were compared at baseline in sociodemographic and clinical variables. We performed a repeated-measures analysis of variance (ANOVA) to test group differences on the PANSS negative subscales. If parametric assumptions were not met, a bootstrapped ANOVA was performed at 2000 iterations. Treatment condition (IRT vs IRT + MBI) was set as the between-subjects factor and time (pretreatment and post-treatment) as the within-subjects factor. Interaction components were analyzed using Bonferroni correction. If a statistically significant difference was detected, then reliable change index (RCI) was used to estimate the clinical change[28]. Data were analyzed with IBM SPSS 29 for Windows. Statistical significance was set at 0.05.

RESULTS

Fifty-two participants were recruited and randomly allocated to the IRT group or the IRT + MBI group. We found no statistically significant differences in demographic or clinical variables before treatment started. Table 2 shows detailed data about demographic and clinical features of the sample. Analysis of the parametric assumptions showed that none of the variables met normality. Before treatment started the scores on lack of spontaneity and flow of conversation (W = 4.42, P = 0.041) and stereotyped thinking (W = 5.97, P = 0.018) did not meet the homoscedasticity assumption. After treatment ended, the subscales that did not meet homoscedasticity were emotional withdrawal (W = 4.95, P = 0.031) and stereotyped thinking (W = 15.5, P < 0.001). Given the violation of the parametric assumptions all the analyses were bootstrapped. Participants on average attended 91.58% of the 26 mindfulness sessions, with attendance ranging from 21 to 26 sessions.

Table 2 Demographic and clinical features of the sample.

Total sample (n = 52)
IRT (n = 26)
IRT + MBI (n = 26)
Statistics
Age, years39.71 ± 8.9840.15 ± 9.3839.42 ± 6.33t = 0.292, P = 0.771
Sex
    Male41 (78.8)21 (80.8)20 (76.9)χ2 = 0.115, P = 0.734
    Female11 (21.2)5 (19.2)6 (23.1)
Years since diagnosis14.13 ± 7.6614.58 ± 8.2213.69 ± 7.20t = 0.413, P = 0.682
Education years12.04 ± 2.0811.93 ± 1.8912.15 ± 2.25t = -0.399, P = 0.691
Diagnosis
    Paranoid schizophrenia23 (44.2)11 (42.3)12 (43.2)χ2 = 0.134, P = 0.999
    Undifferentiated schizophrenia8 (15.4)4 (15.4)8 (15.4)
    Disorganized schizophrenia4 (7.7)2 (7.7)2 (7.7)
    Schizoaffective disorder11 (21.2)6 (23.1)5 (19.2)
    Bipolar disorder4 (7.7)2 (7.7)2 (7.7)
    Delusional disorder2 (3.8)1 (3.8)1 (3.8)
PANSS
    Positive14.90 ± 5.8014.69 ± 5.2515.11 ± 6.40t = -0.261, P = 0.796
    Negative19.08 ± 4.0119.16 ± 4.0119.00 ± 4.09t = 0.137, P = 0.892
    General36.11 ± 8.6136.50 ± 9.6335.74 ± 7.64t = 0.319, P = 0.751
    Total70.23 ± 15.4670.85 ± 15.2069.61 ± 15.90t = 0.284, P = 0.777

The repeated measures ANOVA on the PANSS negative subscales revealed no differences between groups at pretreatment. Main component analysis showed that there were statistically significant differences for the treatment factor in social withdrawal scores (F = 7.21, P = 0.01, η2 = 0.126) but not for blunted affect (F = 0.67, P = 0.418, η2 = 0.013), emotional withdrawal (F = 3.01, P = 0.089, η2 = 0.057), poor rapport (F = 0.02, P = 0.88, η2 < 0.001), difficulty in abstract thinking (F = 0.16, P = 0.692, η2 = 0.003), lack of spontaneity and flow of conversation (F = 0.37, P = 0.544, η2 = 0.007), or stereotyped thinking (F = 2.32, P = 0.134, η2 = 0.044). We found statistically significant differences in emotional withdrawal (F = 37.75, P < 0.001, η2 = 0.437), social withdrawal (F = 10.47, P < 0.001, η2 = 0.264), difficulty in abstract thinking (F = 8.05, P = 0.007, η2 = 0.139), and stereotyped thinking (F = 6.52, P = 0.014, η2 = 0.115) for the time factor. However, we did not detect any statistically significant differences for blunted affect (F = 1.4, P = 0.242, η2 = 0.027), poor rapport (F = 1.11, P = 0.297, η2 = 0.022), and lack of spontaneity and flow of conversation (F = 0.48, P = 0.489, η2 = 0.009). The interaction between factors was statistically significant for the scores on emotional withdrawal (F = 37.75, P < 0.001, η2 = 0.437) and social withdrawal (F = 37.75, P < 0.001, η2 = 0.437). Table 3 provides information about the ANOVA main component analyses.

Table 3 Repeated measures analysis of variance on subscales of the positive and negative syndrome scale negative scale.
PANSS negative subscale
Factor
F
P
η2
Blunted affectTreatment0.670.4180.013
Time1.400.2420.027
Treatment x time0.720.4020.014
Emotional withdrawalTreatment3.010.0890.057
Time38.75< 0.0010.437
Treatment x time25.67< 0.0010.339
Poor rapportTreatment0.020.880< 0.001
Time1.110.2970.022
Treatment x time0.120.7270.002
Social withdrawalTreatment7.210.0100.126
Time10.47< 0.0010.264
Treatment x time11.78< 0.0010.287
Difficulty in abstract thinkingTreatment0.160.6920.003
Time8.050.0070.139
Treatment x time0.1610.2480.027
Lack of spontaneity and flow of conversationTreatment0.370.5440.007
Time0.480.4890.009
Treatment x time0.120.7290.002
Stereotyped thinkingTreatment2.320.1340.044
Time6.520.0140.115
Treatment x time0.010.999< 0.001

Bearing in mind that our main hypothesis was based on the interaction between factors, we analyzed the components of the interactions that reached statistical significance. Analysis of the time component revealed that the IRT + MBI group scored significantly lower at post-treatment in emotional withdrawal (F = 63.75, P < 0.001, η2 = 0.56) and social withdrawal (F = 38.01, P < 0.001, η2 = 0.432) compared with the IRT group. Analysis of the treatment component of the interaction showed that the IRT + MBI group scored significantly lower than the IRT group in emotional withdrawal (F = 14.89, P < 0.001, η2 = 0.23) and social withdrawal (F = 22.2, P < 0.001, η2 = 0.307). Table 4 provides detailed information about the complete ANOVA as well as descriptive statistics for each of the above analyses.

Table 4 Analysis of the interaction components of the repeated measures analysis of variance on subscales of the positive and negative syndrome scale negative.
PANSS negative subscale

PRE
POST
F
P
η2
Blunted affectIRT2.54 (1.03)2.77 (0.99)2.060.1570.039
IRT + MBI2.42 (0.94)2.46 (1.10)0.060.8120.001
PRE0.180.2960.004
POST1.120.2960.022
Emotional withdrawalIRT3.85 (1.12)3.69 (1.32)0.670.4170.013
IRT + MBI4.00 (1.36)2.50 (0.86)63.75< 0.0010.560
PRE0.190.6580.004
POST14.89< 0.0010.230
Poor rapportIRT2.38 (0.80)2.46 (0.90)0.250.6220.005
IRT + MBI2.31 (1.09)2.46 (1.14)0.980.3260.019
PRE0.080.7730.002
POST0.010.999< 0.001
Social withdrawalIRT4.08 (1.20)4.12 (1.24)0.030.8570.001
IRT + MBI3.96 (1.31)2.65 (0.98)38.01< 0.0010.432
PRE0.110.7420.002
POST22.20< 0.0010.307
Difficulty in abstract thinkingIRT2.73 (1.18)2.54 (1.27)1.390.2430.027
IRT + MBI2.73 (1.48)2.27 (1.18)8.030.0070.138
PRE0.010.999< 0.001
POST0.620.4340.012
Lack of spontaneity and flow of conversationIRT2.31 (0.88)2.19 (0.85)0.550.4630.011
IRT + MBI2.42 (1.14)2.38 (1.06)0.060.8060.001
PRE0.170.6850.003
POST0.520.4740.010
Stereotyped thinkingIRT1.31 (0.55)1.19 (0.40)3.260.0770.061
IRT + MBI1.15 (0.67)1.04 (0.20)3.250.0780.061
PRE1.410.2410.027
POST3.080.0860.058

RCI estimation for emotional withdrawal scores revealed that 13 out of 26 participants in the IRT + MBI group and 3 out of 26 in the IRT group showed a reliable change, with a statistically significant difference between groups (χ2 = 9.691, P = 0.002). Similarly, RCI estimation on social withdrawal scores found that 5 out of 26 in the IRT group exhibited a reliable change as did 13 out of 26 in the IRT + MBI group. This difference between groups on the RCI estimation was found statistically significant (χ2 = 5.438, P = 0.02).

DISCUSSION

The main finding of our study was that mindfulness added to standard rehabilitation treatment improved emotional and social withdrawal in people experiencing psychosis. Also, we found that the improvement was superior in patients allocated to the mindfulness group than those allocated to rehabilitation treatment alone. Participants allocated to the IRT + MBI group improved their scores on emotional withdrawal compared to those allocated to IRT alone. This finding was similar to prior research about the beneficial effects of mindfulness on emotion regulation[29,30]. The improvement on emotional withdrawal can be accounted to teaching how to “let go” of the psychotic experiences instead of reacting with avoidance or struggle. This is a core component of mindfulness applied to psychosis[15,17,31] and a fundamental difference with the IRT intervention implemented in our study.

A prior study based on focus groups and grounded theory analysis[32] reported that accepting psychotic sensations is a therapeutic process central to mindfulness interventions that help patients to release self-defeating reactions and increase insight[14]. As shown by López-Navarro and Al-Halabí[33], this attitude is generalized to other contexts. Therefore, participants in the IRT + MBI group could develop an increased interest and involvement with daily-life events resulting in a reduction of their emotional withdrawal.

Our study also found that participants in the IRT + MBI group reduced their scores on social withdrawal when treatment ended, and this reduction was superior to the IRT group. This suggests that participants attending mindfulness sessions not only increased their interest and initiative in social interaction but also enhanced their involvement in social activities. This effect may be attributed to the effect of mindfulness on oneself[34] as well as to the dynamic nature of the self, which is constructed and modified through interactive social engagements[35,36].

Mindfulness for psychosis primarily focuses on developing and embracing a new perception of self. Initially, people with psychosis often view themselves negatively and are influenced by overpowering voices, negative beliefs, and previous traumas, leading to feelings of being inherently bad, inadequate, and worthless[37]. Through regular practice of mindfulness tailored to psychotic experiences, people begin to understand that their identity is not solely defined by their psychosis. This realization fosters the emergence of a new self-concept that is both balanced by acknowledging both positive and negative aspects and dynamic with the capability to change[38]. Ultimately, this new self facilitates conditions for more frequent and engaged interactions within an individual’s social context. This potential explanation is convergent with prior research attesting the relationship between mindfulness practice and improved social interaction[39,40].

It is important to note that we found no statistically significant effect of MBI combined with IRT on certain dimensions of negative symptoms, such as blunted affect, poor rapport, difficulty in abstract thinking, lack of spontaneity and flow of conversation, and stereotyped thinking. The lack of effect may be attributed to differences in the underlying mechanisms of these symptoms[41]. While MBIs are particularly effective in addressing motivational deficits by enhancing present moment awareness, emotional engagement, and social participation[42], expressive deficits and cognitive impairments may require more targeted interventions. Dimensions like blunted affect and poor rapport, which involve verbal and non-verbal expressive behaviors, might benefit from interventions explicitly focused on communication training. Similarly, symptoms such as difficulty in abstract thinking and stereotyped thinking, which are tied to cognitive rigidity, may respond better to cognitive remediation or interventions aimed at improving executive functioning.

Furthermore, the intervention did not involve the families of participants, who often play a crucial role in the recovery process and are significantly affected by the diagnosis of psychosis[43]. Integrating family-focused approaches could provide a more supportive environment for comprehensively addressing negative symptoms[44]. Additionally, the duration and intensity of the intervention in the present study may not have been sufficient to induce significant changes in more entrenched or complex symptoms. These findings highlight the need for future research to explore complementary or alternative approaches tailored to address the full spectrum of negative symptoms in psychosis[45].

The clinical relevance of these findings is highlighted by providing the first data on how the combination of IRT with mindfulness reduces negative psychotic symptoms, specifically by decreasing emotional and social withdrawal. Moreover, our study was conducted in a real-world setting that increases the external validity of the findings. The findings contribute to the design and optimization of treatment strategies for people with psychosis. Individuals exhibiting greater social and emotional withdrawal may potentially benefit to a greater extent from the inclusion of mindfulness in their rehabilitation treatment. Finally, our findings lend further support to the idea that integrating MBI with rehabilitation treatment for psychosis represents a promising approach for enhancing recovery in this client group.

Our study has strengths and limitations that deserve mention. The main strengths of the study were the use of a randomized controlled trial design, the use of well-validated measurement instruments, the use of a reliable assessment process through videotaped clinical interviews to tap negative symptom manifestations, and the interventions integrated with daily routines of the rehabilitation center. The main limitation was the sample size, which may limit the generalization of the findings, although it was enough to test the main hypothesis. Furthermore, the sample was disproportionately male. While that is reflective of the epidemiological prevalence of psychotic disorders in Spain, it could influence the outcomes. Also, home practice was not measured, which may compromise the interpretation of the findings as it may moderate the effect of the interventions. Additionally, we did not measure the long-term effects of the intervention. Further research should address these limitations and evaluate the cost-effectiveness of both treatment arms. Also, future research should study the influence of moderate variables like social stigma and the effect of mindfulness on the family and caregivers of people receiving rehabilitation treatment[46].

CONCLUSION

Our study was the first to provide detailed data on the specific effects of incorporating mindfulness into rehabilitation treatment on each component of negative psychotic symptoms. Several studies have shown that MBIs reduce negative psychotic symptoms. Our study extended these findings by identifying a reduction in social and emotional withdrawal as key factors contributing to this decrease in negative psychotic symptoms. Furthermore, our results highlighted the combination of rehabilitation treatment with MBIs is more effective in reducing negative symptoms than rehabilitation treatment alone. The clinical relevance of our findings lies in the potential to optimize rehabilitation treatment for people experiencing psychosis and enhance their recovery.

ACKNOWLEDGEMENTS

We are very grateful to all the patients who took part in this study. Also, we thank all the health professionals that provide us with administrative support. We would also like to express our gratitude to Dr. Guido Corradi for his review of the statistical procedures implemented.

Footnotes

Provenance and peer review: Unsolicited article; Externally peer reviewed.

Peer-review model: Single blind

Specialty type: Psychiatry

Country of origin: Spain

Peer-review report’s classification

Scientific Quality: Grade B, Grade B

Novelty: Grade A, Grade B

Creativity or Innovation: Grade B, Grade B

Scientific Significance: Grade B, Grade B

P-Reviewer: Zhang JJ S-Editor: Wei YF L-Editor: Filipodia P-Editor: Zhao YQ

References
1.  Sampietro HM, Rojo E, Gómez-benito J. Recovery-oriented Care in Public Mental Health Policies in Spain: Opportunities and Barriers. Clínica y Salud. 2023;34:35-40.  [PubMed]  [DOI]  [Cited in This Article: ]  [Reference Citation Analysis (0)]
2.  Lenzenweger MF  Schizotypy, schizotypic psychopathology, and schizophrenia: Understanding the nature, basis, and manifestation of the schizophrenia spectrum. In: Butcher JN, Hooley JM. APA handbook of psychopathology: Psychopathology: Understanding, assessing, and treating adult mental disorders. Washington, DC: American Psychological Association, 2018: 343-373.  [PubMed]  [DOI]  [Cited in This Article: ]
3.  Schultz SH, North SW, Shields CG. Schizophrenia: a review. Am Fam Physician. 2007;75:1821-1829.  [PubMed]  [DOI]  [Cited in This Article: ]
4.  Moreno-Küstner B, Martín C, Pastor L. Prevalence of psychotic disorders and its association with methodological issues. A systematic review and meta-analyses. PLoS One. 2018;13:e0195687.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 178]  [Cited by in RCA: 288]  [Article Influence: 41.1]  [Reference Citation Analysis (0)]
5.  Kadakia A, Catillon M, Fan Q, Williams GR, Marden JR, Anderson A, Kirson N, Dembek C. The Economic Burden of Schizophrenia in the United States. J Clin Psychiatry. 2022;83:22m14458.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 1]  [Cited by in RCA: 65]  [Article Influence: 21.7]  [Reference Citation Analysis (0)]
6.  Sabe M, Zhao N, Crippa A, Kaiser S. Antipsychotics for negative and positive symptoms of schizophrenia: dose-response meta-analysis of randomized controlled acute phase trials. NPJ Schizophr. 2021;7:43.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 27]  [Cited by in RCA: 30]  [Article Influence: 7.5]  [Reference Citation Analysis (0)]
7.  Galderisi S, Kaiser S, Bitter I, Nordentoft M, Mucci A, Sabé M, Giordano GM, Nielsen MØ, Glenthøj LB, Pezzella P, Falkai P, Dollfus S, Gaebel W. EPA guidance on treatment of negative symptoms in schizophrenia. Eur Psychiatry. 2021;64:e21.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 26]  [Cited by in RCA: 82]  [Article Influence: 20.5]  [Reference Citation Analysis (0)]
8.  Kantrowitz JT. How do we address treating the negative symptoms of schizophrenia pharmacologically? Expert Opin Pharmacother. 2021;22:1811-1813.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 3]  [Cited by in RCA: 2]  [Article Influence: 0.5]  [Reference Citation Analysis (0)]
9.  Howes O, Fusar-Poli P, Osugo M. Treating negative symptoms of schizophrenia: current approaches and future perspectives. Br J Psychiatry. 2023;223:332-335.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in RCA: 9]  [Reference Citation Analysis (0)]
10.  Cella M, Roberts S, Pillny M, Riehle M, O'Donoghue B, Lyne J, Tomlin P, Valmaggia L, Preti A. Psychosocial and behavioural interventions for the negative symptoms of schizophrenia: a systematic review of efficacy meta-analyses. Br J Psychiatry. 2023;223:321-331.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in RCA: 21]  [Reference Citation Analysis (0)]
11.  Ellett L. Mindfulness for psychosis: Current evidence, unanswered questions and future directions. Psychol Psychother. 2024;97:34-40.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 5]  [Cited by in RCA: 2]  [Article Influence: 2.0]  [Reference Citation Analysis (0)]
12.  Qin K, Yu Y, Cai H, Li J, Zeng J, Liang H. Effectiveness of mindfulness-based intervention in schizophrenia: A meta-analysis of randomized controlled trials. Psychiatry Res. 2024;334:115808.  [PubMed]  [DOI]  [Cited in This Article: ]  [Reference Citation Analysis (0)]
13.  Ellett L, Chadwick P. Recommendations for monitoring and reporting harm in mindfulness for psychosis research. Br J Psychiatry. 2021;219:629-631.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 6]  [Cited by in RCA: 9]  [Article Influence: 2.3]  [Reference Citation Analysis (0)]
14.  Chadwick P. Mindfulness for psychosis: a humanising therapeutic process. Curr Opin Psychol. 2019;28:317-320.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 9]  [Cited by in RCA: 9]  [Article Influence: 1.5]  [Reference Citation Analysis (0)]
15.  Errasti-pérez J, Al-halabí S, López-navarro E, Pérez-álvarez M. Mindfulness: Why it may work and why it is sure to succeed. Behav Psychol. 2022;30:235-248.  [PubMed]  [DOI]  [Cited in This Article: ]
16.  López-Navarro E, Del Canto C, Belber M, Mayol A, Fernández-Alonso O, Lluis J, Munar E, Chadwick P. Mindfulness improves psychological quality of life in community-based patients with severe mental health problems: A pilot randomized clinical trial. Schizophr Res. 2015;168:530-536.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 40]  [Cited by in RCA: 34]  [Article Influence: 3.4]  [Reference Citation Analysis (0)]
17.  Jansen JE, Gleeson J, Bendall S, Rice S, Alvarez-Jimenez M. Acceptance- and mindfulness-based interventions for persons with psychosis: A systematic review and meta-analysis. Schizophr Res. 2020;215:25-37.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 56]  [Cited by in RCA: 75]  [Article Influence: 15.0]  [Reference Citation Analysis (0)]
18.  Jacobsen P, Richardson M, Harding E, Chadwick P. Mindfulness for Psychosis Groups; Within-Session Effects on Stress and Symptom-Related Distress in Routine Community Care. Behav Cogn Psychother. 2019;47:421-430.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 4]  [Cited by in RCA: 3]  [Article Influence: 0.5]  [Reference Citation Analysis (0)]
19.  Villota-tamayo Á, Ricco-pérez M, Borrás-sansaloni C, López-navarro E. Dispositional Mindfulness Mediates the Relationship between Psychotic Symptoms and Psychological Quality of Life. Clínica y Salud. 2024;35:1-3.  [PubMed]  [DOI]  [Cited in This Article: ]
20.  López-Navarro E, Fonseca-Pedrero E, Errasti J, Al-Halabí S. Mindfulness improves theory of mind in people experiencing psychosis: A pilot randomized clinical trial. Psychiatry Res. 2022;310:114440.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in RCA: 1]  [Reference Citation Analysis (0)]
21.  Mediavilla R, Muñoz-Sanjose A, Rodriguez-Vega B, Lahera G, Palao A, Bayon C, Vidal-Villegas MP, Chadwick P, Bravo-Ortiz MF. People with psychosis improve affective social cognition and self-care after a mindfulness-based social cognition training program (SocialMIND). Psychiatr Rehabil J. 2021;44:391-395.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 1]  [Cited by in RCA: 5]  [Article Influence: 1.3]  [Reference Citation Analysis (0)]
22.  López-Navarro E, Del Canto C, Mayol A, Fernández-Alonso O, Reig J, Munar E. Does mindfulness improve inhibitory control in psychotic disorders? A randomized controlled clinical trial. Int J Clin Health Psychol. 2020;20:192-199.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 10]  [Cited by in RCA: 10]  [Article Influence: 2.0]  [Reference Citation Analysis (0)]
23.  Shen H, Zhang L, Li Y, Zheng D, Du L, Xu F, Xu C, Liu Y, Shen J, Li Z, Cui D. Mindfulness-based intervention improves residual negative symptoms and cognitive impairment in schizophrenia: a randomized controlled follow-up study. Psychol Med. 2023;53:1390-1399.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 4]  [Cited by in RCA: 8]  [Article Influence: 4.0]  [Reference Citation Analysis (0)]
24.  MacDougall AG, Wiener JC, Puka K, Price E, Oyewole-Eletu O, Gardizi E, Anderson KK, Norman RMG. Effectiveness of a mindfulness-based intervention for persons with early psychosis: A multi-site randomized controlled trial. Schizophr Res. 2024;264:502-510.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 1]  [Reference Citation Analysis (0)]
25.  Chai J, Xiao X, An N, Liu F, Liu S, Hu N, Yang Y, Cui Y, Li Y. Efficacy of Mindfulness-Based Interventions for Negative Symptoms in Patients Diagnosed with Schizophrenia: a Meta-analysis. Mindfulness. 2022;13:2069-2081.  [PubMed]  [DOI]  [Cited in This Article: ]
26.  Peralta Martín V, Cuesta Zorita MJ. [Validation of positive and negative symptom scale (PANSS) in a sample of Spanish schizophrenic patients]. Actas Luso Esp Neurol Psiquiatr Cienc Afines. 1994;22:171-177.  [PubMed]  [DOI]  [Cited in This Article: ]
27.  López-Navarro E, Del Canto C, Mayol A, Fernández-Alonso O, Munar E. Psychotic symptoms and quality of life: A mediation analysis of daily-life coping. Psychiatry Res. 2018;262:505-509.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 10]  [Cited by in RCA: 10]  [Article Influence: 1.4]  [Reference Citation Analysis (0)]
28.  Christensen L, Mendoza JL. A method of assessing change in a single subject: An alteration of the RC index. Behav Ther. 1986;17:305-308.  [PubMed]  [DOI]  [Cited in This Article: ]
29.  Raugh IM, Strauss GP. Integrating mindfulness into the extended process model of emotion regulation: The dual-mode model of mindful emotion regulation. Emotion. 2024;24:847-866.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 1]  [Reference Citation Analysis (0)]
30.  Schuman-Olivier Z, Trombka M, Lovas DA, Brewer JA, Vago DR, Gawande R, Dunne JP, Lazar SW, Loucks EB, Fulwiler C. Mindfulness and Behavior Change. Harv Rev Psychiatry. 2020;28:371-394.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 180]  [Cited by in RCA: 110]  [Article Influence: 27.5]  [Reference Citation Analysis (0)]
31.  Louise S, Fitzpatrick M, Strauss C, Rossell SL, Thomas N. Mindfulness- and acceptance-based interventions for psychosis: Our current understanding and a meta-analysis. Schizophr Res. 2018;192:57-63.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 88]  [Cited by in RCA: 105]  [Article Influence: 15.0]  [Reference Citation Analysis (0)]
32.  Abba N, Chadwick P, Stevenson C. Responding mindfully to distressing psychosis: A grounded theory analysis. Psychother Res. 2008;18:77-87.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 107]  [Cited by in RCA: 92]  [Article Influence: 5.4]  [Reference Citation Analysis (0)]
33.  López-Navarro E, Al-Halabí S. Mindfulness on Daily Life Coping in People Experiencing Psychosis: A Randomized Controlled Trial. Int J Clin Health Psychol. 2022;22:100298.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 2]  [Cited by in RCA: 2]  [Article Influence: 0.7]  [Reference Citation Analysis (0)]
34.  Lundh L. Experimental Phenomenology in Mindfulness Research. Mindfulness. 2020;11:493-506.  [PubMed]  [DOI]  [Cited in This Article: ]
35.  Mascolo MF, Bhatia S. The Dynamic Construction of Culture, Self and Social Relations. Psychol Dev Soc. 2002;14:55-89.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 7]  [Cited by in RCA: 7]  [Article Influence: 0.8]  [Reference Citation Analysis (0)]
36.  Gergen KJ  The Social Construction of Self. In: Gallagher S. Oxford Handbooks Online. Oxford: Oxford University Press, 2011.  [PubMed]  [DOI]  [Cited in This Article: ]
37.  Steele A, Chadwick P, McCabe R. Let's Talk About Psychosis. Clin Schizophr Relat Psychoses. 2018;12:69-76.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 1]  [Cited by in RCA: 3]  [Article Influence: 0.3]  [Reference Citation Analysis (0)]
38.  Ellett L, Dannahy L, Chadwick P. Engagement, clinical outcomes and therapeutic process in online mindfulness for psychosis groups delivered in routine care. Psychol Psychother. 2022;95:467-476.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 1]  [Cited by in RCA: 3]  [Article Influence: 1.0]  [Reference Citation Analysis (0)]
39.  Ketay S, Thorson KR, Roy ARK, Welker KM. Trait Mindfulness is Associated with Self-Disclosure and Responsiveness During Social Interactions with New Acquaintances. Mindfulness. 2023;14:205-217.  [PubMed]  [DOI]  [Cited in This Article: ]
40.  Lindsay EK, Young S, Brown KW, Smyth JM, Creswell JD. Mindfulness training reduces loneliness and increases social contact in a randomized controlled trial. Proc Natl Acad Sci U S A. 2019;116:3488-3493.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 115]  [Cited by in RCA: 123]  [Article Influence: 20.5]  [Reference Citation Analysis (0)]
41.  Strauss GP, Gold JM. A new perspective on anhedonia in schizophrenia. Am J Psychiatry. 2012;169:364-373.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 246]  [Cited by in RCA: 265]  [Article Influence: 20.4]  [Reference Citation Analysis (0)]
42.  Chadwick P. Mindfulness for psychosis. Br J Psychiatry. 2014;204:333-334.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 73]  [Cited by in RCA: 69]  [Article Influence: 6.9]  [Reference Citation Analysis (0)]
43.  Reyes-gonzález C, Pérez-marfil MN, Roldán GM, Salazar IC. Psychological Intervention on Health, Self-Esteem, and Coping in Siblings of Patients with Severe Mental Disorders. Clínica y Salud. 2024;35:85-93.  [PubMed]  [DOI]  [Cited in This Article: ]
44.  Bighelli I, Rodolico A, García-Mieres H, Pitschel-Walz G, Hansen WP, Schneider-Thoma J, Siafis S, Wu H, Wang D, Salanti G, Furukawa TA, Barbui C, Leucht S. Psychosocial and psychological interventions for relapse prevention in schizophrenia: a systematic review and network meta-analysis. Lancet Psychiatry. 2021;8:969-980.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 54]  [Cited by in RCA: 112]  [Article Influence: 28.0]  [Reference Citation Analysis (0)]
45.  Estradé A, Spencer TJ, De Micheli A, Murguia-Asensio S, Provenzani U, McGuire P, Fusar-Poli P. Mapping the implementation and challenges of clinical services for psychosis prevention in England. Front Psychiatry. 2022;13:945505.  [PubMed]  [DOI]  [Cited in This Article: ]  [Reference Citation Analysis (0)]
46.  Zamorano S, Sáez-alonso M, González-sanguino C, Muñoz M. Social Stigma Towards Mental Health Problems in Spain: A Systematic Review. Clínica y Salud. 2023;34:23-34.  [PubMed]  [DOI]  [Cited in This Article: ]  [Reference Citation Analysis (0)]